Samlyn Capital’s SomaLogic Warrant SLGCW Stock Holding History
Bought
Maintained
Sold
Other funds holding SLGCW
Samlyn Capital's SLGCW Position: Q2 2022 in Review
Samlyn Capital sold out of SomaLogic Warrant (SLGCW) in Q2 2022, closing a stake of 75,880 shares — an estimated $162K sold.
Samlyn Capital first reported a position in SLGCW in Q2 2021 and held it in 4 quarters. The position peaked at $390K in Q2 2021. 28 funds tracked by Wall St. Rank hold SLGCW as of Q2 2022.
- Samlyn Capital reported no remaining SomaLogic Warrant position as of Q2 2022 after selling out during the quarter.
- Samlyn Capital sold 75,880 SomaLogic Warrant shares in Q2 2022, an estimated $162K.
- Samlyn Capital first reported a position in SomaLogic Warrant in Q2 2021 and held it in 4 quarters.
- Samlyn Capital's SomaLogic Warrant position peaked at $390K in Q2 2021.
- 28 funds tracked by Wall St. Rank held SomaLogic Warrant as of Q2 2022.
Based on Samlyn Capital's 13F filing for Q2 2022, filed 15 Aug 2022.